Engineering of Brome Mosaic Virus for Biomedical Applications
Overview
Authors
Affiliations
Viral nanoparticles (VNPs) are becoming versatile tools in platform technology development. Their well-defined structures as well as their programmability through chemical and genetic modification allow VNPs to be engineered for potential imaging and therapeutic applications. In this article, we report the application of a variety of bioconjugation chemistries to the plant VNP (BMV). Functional BMV nanoparticles displaying multiple copies of fluorescent dyes, PEG molecules, chemotherapeutic drug moieties, targeting proteins and cell penetrating peptides were formulated. This opens the door for the application of BMV in nanomedicine.
Chen X, Luo J, Song M, Pan L, Qu Z, Huang B Front Aging Neurosci. 2024; 16:1342366.
PMID: 38389560 PMC: 10882099. DOI: 10.3389/fnagi.2024.1342366.
The diversity of protein-protein interaction interfaces within T=3 icosahedral viral capsids.
Prakash D, Gosavi S Front Mol Biosci. 2022; 9:967877.
PMID: 36339706 PMC: 9631432. DOI: 10.3389/fmolb.2022.967877.
Gonzalez-Gamboa I, Velazquez-Lam E, Lobo-Zegers M, Frias-Sanchez A, Tavares-Negrete J, Monroy-Borrego A Front Bioeng Biotechnol. 2022; 10:907601.
PMID: 36118588 PMC: 9480610. DOI: 10.3389/fbioe.2022.907601.
Subset of Fluorophores Is Responsible for Radiation Brightening in Viromimetic Particles.
Sushma A, Zhao B, Tsvetkova I, Perez-Segura C, Hadden-Perilla J, Reilly J J Phys Chem B. 2021; 125(37):10494-10505.
PMID: 34507491 PMC: 9009136. DOI: 10.1021/acs.jpcb.1c06395.
Strategies for delivering therapeutics across the blood-brain barrier.
Terstappen G, Meyer A, Bell R, Zhang W Nat Rev Drug Discov. 2021; 20(5):362-383.
PMID: 33649582 DOI: 10.1038/s41573-021-00139-y.